CJC-1295 / Ipamorelin NO DAC 10mg — Growth Hormone Secretagogue Research Stack
CJC-1295 (without DAC) and Ipamorelin represent two of the most studied growth hormone secretagogue peptides in modern longevity and performance research. When combined in a single research vial, they deliver complementary mechanisms of growth hormone release — CJC-1295 as a GHRH analogue and Ipamorelin as a selective ghrelin receptor agonist — creating a synergistic protocol widely referenced in GH optimization and anti-aging research.
Product Overview
CJC-1295 without DAC (Modified GRF 1-29) is a synthetic analogue of growth hormone-releasing hormone (GHRH) with a 30-minute half-life, stimulating pulsatile GH release from the anterior pituitary in a manner that closely mimics natural GH physiology. Ipamorelin is a selective GHSR agonist — a ghrelin mimetic — that stimulates GH release through a completely different receptor pathway, with minimal effect on cortisol or prolactin at research doses.
The combination leverages both the GHRH axis and the ghrelin axis, producing synergistic GH secretion greater than either compound alone.
Key Benefits
- Synergistic GH release — dual-pathway stimulation produces greater GH output than either peptide alone
- Pulsatile GH physiology — mimics natural GH release patterns
- IGF-1 upregulation — downstream GH signaling elevates IGF-1 for anabolic and regenerative research
- Body composition research — GH-mediated fat metabolism and lean mass preservation
- Recovery and sleep quality — GH secretion is primarily nocturnal; studied for sleep-related restoration
- Anti-aging research — GH/IGF-1 axis modulation relevant to healthy aging biology
- Selective Ipamorelin action — minimal cortisol or prolactin stimulation
- Bone density and connective tissue — GH-mediated effects on skeletal health
Popular Use Cases
CJC-1295/Ipamorelin research spans longevity medicine, body composition science, anti-aging research, and sleep biology. Among the most referenced GH secretagogue stacks for studying the GH/IGF-1 axis, age-related GH decline, and metabolic health optimization.
Who Commonly Uses This
Endocrinologists, anti-aging researchers, longevity scientists, and body composition researchers represent the primary research populations. Biohackers and precision wellness practitioners following GH optimization research also closely reference this combination.
Product Details
| Combination | CJC-1295 (No DAC) 5mg + Ipamorelin 5mg |
| Total Content | 10mg per vial |
| Format | Lyophilized powder |
| BAC Water | Included |
| Purity | ≥99% HPLC verified |
| Storage (lyophilized) | 2–8°C, away from light |
| Storage (reconstituted) | 2–8°C, use within 30 days |
| Research Use | For laboratory and research purposes only |
Storage & Handling
Store lyophilized at 2–8°C away from light. Avoid freeze-thaw cycles. Once reconstituted, refrigerate and use within 28–30 days.
Research & Scientific Interest
CJC-1295 without DAC mimics endogenous GHRH pulses with a 30-minute half-life. Ipamorelin’s selectivity for GHSR-1a with minimal cortisol or prolactin stimulation makes it one of the cleanest GH secretagogues studied. Together, they are cited extensively in GH axis research, longevity biology, and body composition science.
Frequently Asked Questions
A research combination of CJC-1295 No DAC (GHRH analogue, 5mg) and Ipamorelin (ghrelin receptor agonist, 5mg) that synergistically stimulates growth hormone release via two complementary pathways.
CJC-1295 WITHOUT DAC has a ~30-minute half-life, producing pulsatile GH release that closely mimics natural physiology, compared to CJC-1295 WITH DAC which has a ~7-day half-life.
CJC-1295 stimulates GH via the GHRH receptor. Ipamorelin stimulates GH via the ghrelin receptor. Combining both produces synergistic GH secretion significantly greater than either alone.
Yes. Ipamorelin has high selectivity for GHSR-1a with minimal cortisol, prolactin, or ACTH stimulation — making it one of the cleanest GH secretagogues in research.
Yes. Each vial includes bacteriostatic water for reconstitution.
Store lyophilized at 2–8°C away from light. Once reconstituted, refrigerate and use within 28–30 days.
No. Strictly for laboratory and research purposes only.
Yes. H&J Pharma offers same-day shipping with next-day delivery across Vietnam.
Research References
- Teichman SL, et al. “Prolonged stimulation of growth hormone and IGF-1 secretion by CJC-1295.” Journal of Clinical Endocrinology & Metabolism. 2006. PubMed
- Bowers CY, et al. “Ipamorelin, the first selective growth hormone secretagogue.” European Journal of Endocrinology. 1998. PubMed
- Hartman ML, et al. “GHRH and GH secretagogue synergy.” Journal of Clinical Endocrinology & Metabolism. 1992. PubMed
- Raun K, et al. “Ipamorelin — a selective GH secretagogue.” European Journal of Endocrinology. 1998.
- Muller EE, et al. “Neuroendocrine control of GH secretion.” Physiological Reviews. 1999. PubMed
- Howard AD, et al. “A receptor in pituitary and hypothalamus for growth hormone release.” Science. 1996. PubMed
- Giustina A, Veldhuis JD. “Pathophysiology of GH neuroregulation.” Endocrine Reviews. 1998. PubMed
- Frohman LA, Jansson JO. “Growth hormone-releasing hormone.” Endocrine Reviews. 1986. PubMed
- Alba M, et al. “CJC-1295 stimulates GH and IGF-1 secretion.” JCEM. 2006.
- Sigalos JT, Pastuszak AW. “The Safety and Efficacy of Growth Hormone Secretagogues.” Sexual Medicine Reviews. 2018. PubMed
Lifestyle & Wellness Context
The CJC-1295/Ipamorelin stack has become one of the most referenced GH secretagogue protocols in longevity and performance research. H&J Pharma supplies this stack at HPLC-verified ≥99% purity with same-day shipping across Vietnam.
Related Wellness Research Areas
Research communities studying GH axis biology, IGF-1 signaling, anti-aging endocrinology, body composition, sleep and recovery, and longevity medicine will find this one of the most referenced GH secretagogue combinations.
Reviews
There are no reviews yet.